WebDisclosure WebDisclosure
Basculer en Français
9547 Companies
188173 Keywords
120057 Articles
100509 Press releases
Headlines Articles Press releases World Tumor Registry, Inc Remove
  1. Home
  2. Companies
  3. World Tumor Registry, Inc
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/06/2025 at 14:05, 10 months 11 days ago

    World Tumor Registry Appoints Dr. Edi Brogi as Head of Breast Cancer Registry

    Medical Research Breast Cancer Pathology World Tumor Registry Dr. Edi Brogi
  • BRIEF

    published on 02/06/2025 at 14:05, 10 months 11 days ago

    Le World Tumor Registry nomme le Dr Edi Brogi à la tête du registre du cancer du sein

    Recherche Médicale Cancer Du Sein Pathologie Registre Mondial Des Tumeurs Dr Edi Brogi
  • PRESS RELEASE

    published on 02/06/2025 at 14:00, 10 months 11 days ago

    World Tumor Registry Names Dr. Edi Brogi as Inaugural Chair of its Breast Cancer Registry

    World Tumor Registry expands with Breast Cancer Registry project led by Dr. Edi Brogi, aiming to create comprehensive open-access repository of cancer images and data
    World Tumor Registry Dr. Edi Brogi Breast Cancer Registry Cancer Images Open-access Catalog
    Logo of World Tumor Registry, Inc
Accesswire
  • Published on 12/18/2025 at 00:55, 3 hours ago

    Molten Metals Corp. Announces Flow-Through Financing

  • Published on 12/18/2025 at 00:00, 3 hours 55 minutes ago

    Right Season Investments Announces Name Change to FutureGen Industries Corp.

  • Published on 12/17/2025 at 23:15, 4 hours 40 minutes ago

    Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.

  • Published on 12/17/2025 at 15:00, 12 hours 55 minutes ago

    BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations

  • Published on 12/17/2025 at 14:00, 13 hours 55 minutes ago

    UniDoc Completes H3 Health Cube Installation in Italy

View all ACCESSWIRE
EQS Group
  • Published on 12/18/2025 at 01:10, 2 hours 45 minutes ago

    Samsung To Unveil New AI-Connected Living Lineup at CES 2026

  • Published on 12/18/2025 at 00:50, 3 hours 5 minutes ago

    Historic production of graphene enhanced cement successfully completed

  • Published on 12/17/2025 at 22:05, 5 hours 50 minutes ago

    Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques

  • Published on 12/17/2025 at 22:05, 5 hours 50 minutes ago

    Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

  • Published on 12/17/2025 at 21:22, 6 hours 33 minutes ago

    EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share

View all EQS
Les Echos
  • Published on 12/17/2025 at 20:39, 7 hours 16 minutes ago

    Aeroports de Paris SA | 2026 Airport charges in Paris

  • Published on 12/17/2025 at 20:39, 7 hours 16 minutes ago

    Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris

  • Published on 12/17/2025 at 19:30, 8 hours 25 minutes ago

    Change in the composition of the Board

  • Published on 12/17/2025 at 19:30, 8 hours 25 minutes ago

    Evolution de la composition du Conseil d’Administration

  • Published on 12/17/2025 at 18:00, 9 hours 55 minutes ago

    Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy